Japan Entry Acceleration Program 2026

About

A structured program designed for pioneering companies in regenerative medicine, offering tailored mentorship, market insights, and networking opportunities to facilitate entry into Japan's advanced healthcare market. Participants will engage in workshops, connect with industry leaders, and present their innovations during a Demo Day in Tokyo.

Benefits

• 🎓Mentorship Program
  Access to expert-led workshops and one-on-one mentoring on Japan’s market and regulations.
• 🌐Network Access
  Connect with key partners across Japan’s healthcare ecosystem, including corporates and regulatory experts.
• 📈Business Support
  Opportunities to pitch to investors and potential partners during the Demo Day in Japan.
• 🏢Site Visits
  In-person site visits to enhance relationship building with Japanese companies.
• 💰Financial Support
  JETRO covers one round-trip economy class airfare and accommodation during the official program period.

Eligibility Criteria

• Open to companies focused on regenerative medicine, including cell therapy and gene therapy
• Must have identified clinical development candidates
• Companies must show interest in entering the Japanese market
• Commitment to participate in multiple program sessions, including the Demo Day in Japan.

Participation Commitments

• Must attend multiple online workshops and mentoring sessions from November 2026 to February 2027
• Participation in the on-site Demo Day in Japan in February 2027 is required
• Commitment to engage with Japan’s healthcare ecosystem during the program
• Applications submitted by August 16 will be prioritized for selection.

Target Region

Open to companies looking to enter the Japanese market

Target Sector

Focused on regenerative medicine and healthcare innovation